prx-03140
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2006 (NCT00384423)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Serotonin 4 (5-HT4) receptorPARTIAL AGONIST
HTR4 partial agonist
Chemistry & pharmacology
Loading structure…
SMILES
CC(C)n1c(=O)c(C(=O)NCCCN2CCCCC2)c(O)c2ccsc21- Mol. weight
- 377.51 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3306918 ↗
Also known as
- prx-03140
- prx-03140
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01492699 | N/A | Jun 1, 2012 | Ology Bioservices |
| NCT00693004 | Phase 2 | May 1, 2008 | Epix Pharmaceuticals |
| NCT00672945 | Phase 2 | Apr 1, 2008 | Epix Pharmaceuticals |
| NCT00384423 | Phase 2 | Oct 1, 2006 | Epix Pharmaceuticals |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Epix Pharmaceuticals | For profit | 3 | 3 | 1 | 2006 |
| Ology Bioservices | For profit | 1 | 1 | 1 | 2012 |
2 organizations
Page 1 / 1